Metsera, Inc. MTSR NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

39/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Metsera, Inc. (MTSR) generated $-81.72M in operating cash flow for quarter ending 2025-09-30. After capital expenditures of $0.00, free cash flow was $-81.72M.

Cash conversion ratio was 0.7x, suggesting some earnings are non-cash.

Criteria supported by this page:

HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
MOAT (40/100, Fail) — limited free cash flow weakens the competitive position
INCOME (?/100) — Cash conversion ratio was 0.7x suggests some earnings are non-cash items

Overall SharesGrow Score: 37/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

39/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

✓

FUTURE

75/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

40/100

Proven by this page

✗

GROWTH

15/100

→ Income

—

INCOME

N/A

No coverage

Metsera, Inc. Cash Flow History

Metric	TTM	Q3 FY2025	Q2 FY2025	Q1 FY2025	Q4 FY2024
Operating Cash Flow	$-231.4M	$-81.72M	$-58.96M	$-54.34M	$-36.37M
Capital Expenditure	$-199K	$0.00	$-191K	$-7K	$-1K
Free Cash Flow	$-231.59M	$-81.72M	$-59.16M	$-54.35M	$-36.38M